Amgen (AMGN) Acquisitions (2011 - 2022)

Amgen has reported Acquisitions for 10 years, with the latest figure at $3.8 billion in Q4 2022.

• On a quarterly basis, Acquisitions rose 331.35% year-over-year to $3.8 billion in Q4 2022; TTM through Dec 2022 was $4.7 billion, a 425.14% increase from a year earlier, with the FY2025 full-year figure at $53.0 million, changed N/A from the prior year.
• Acquisitions was $3.8 billion for Q4 2022 at Amgen, up from $890.0 million in the prior quarter.
• The five-year high for Acquisitions was $13.4 billion in Q4 2019, with the low at -$197.0 million in Q1 2018.
• Average Acquisitions over 4 years is $2.6 billion, with a median of $177.0 million recorded in 2019.
• The sharpest annual moves came in 2018 and 2019: Acquisitions sank 89.47% in 2018, then soared 671900.0% in 2019.
• Over 4 years, Acquisitions stood at $2.0 million in 2018, then jumped by 671900.0% to $13.4 billion in 2019, then slumped by 93.38% to $890.0 million in 2021, then soared by 331.35% to $3.8 billion in 2022.
• The last three Acquisitions figures came in at $3.8 billion (Q4 2022), $890.0 million (Q4 2021), and $13.0 million (Q3 2021), per Business Quant data.